ABSIAbsci Corporation

$10.17+289% 1Y

$10.17

$2.3052 weeks$11.53

ABSI in its own filings

Nothing in ABSI's filing record raises a hard flag: no restatement, late filing, bankruptcy or delisting notice, and no auditor change next to one. That is the common case, not a distinction.

110

Events found in the filings · across 355 filings · the record starts in 2021

Hard flags: none
Hard flags
Most recent filing: Aug 11, 2026
Most recent filing · Form 10-Q
Record starts: Jun 4, 2021
Record starts · the earliest filing Ryufin holds for this name

Details›

Next results filingsame week as a year ago: expected around Nov 11, 2026
SEC comment-letter activity19 occurrences: 2025-08-20

SEC EDGAR submissions index and 8-K item codes; 4.02 and 1.03 items are confirmed against the filing text.

What the company said

The company's own words from its current reports to the SEC, newest first

Aug 11, 2026From time to time, the Company presents and/or distributes slides and presentations to the investment community to provide updates and summaries of its business.Earnings release · Form 8-K
Jun 24, 2026On June 24, 2026, Absci Corporation issued a press release announcing Interim Phase 1 Data from the HEADLINE™ Trial of ABS-201.Other event · Form 8-K
Jun 24, 2026On June 24, 2026, Absci Corporation (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with Jefferies LLC, J.P. Morgan Securities LLC, TD Securities (USA) LLC and Guggenheim Securities, LLC (the “Underwriters”), relating to the issuance and sale of an aggregate of 13,495,277 shares …Material agreement entered · Form 8-K
May 7, 2026From time to time, the Company presents and/or distributes slides and presentations to the investment community to provide updates and summaries of its business.Earnings release · Form 8-K
Mar 24, 2026From time to time, the Company presents and/or distributes slides and presentations to the investment community to provide updates and summaries of its business.Earnings release · Form 8-K
Mar 6, 2026On March 6, 2026 the Board of Directors of Absci Corporation (the “Company”) approved amended and restated forms of director and officer indemnification agreements (the “A&R Form Indemnification Agreements”) to be entered into by the Company and each of its current directors and officers (which form the Company …Material agreement entered · Form 8-K
Jan 14, 2026On January 14, 2026, Absci Corporation (the "Company") will present a business update at the 44th Annual J.P. Morgan Healthcare Conference.Other event · Form 8-K
Nov 12, 2025From time to time, the Company presents and/or distributes slides and presentations to the investment community to provide updates and summaries of its business.Earnings release · Form 8-K
Nov 4, 2025On October 31, 2025, Absci Corporation (the “Company”) executed a Letter Agreement (the “Letter Agreement”) with SBGH, LLC (“SBGH”), which supplements and amends that certain Agreement and Plan of Merger (the “Merger Agreement”), dated as of June 4, 2021, by and among the Company, Target Discovery Merger Sub I, Inc. …Material agreement entered · Form 8-K